Key result
CV risk factors increase individual medical costs, but prevalent mild-to-moderate levels drive population-level economic burden.
Why the study?
Few Japanese epidemiological studies analysing data on health checkups and medical insurance have provided evidence on the relationship between cardiovascular risk factors and medical expenditure.
Does management of cardiovascular risk factors reduce medical expenditure in the Japanese population?
Does management of cardiovascular risk factors reduce medical expenditure in the Japanese population?
Cardiovascular risk factors require management using both high-risk and population-based strategies to effectively reduce the medical economic burden.
Supports dual high-risk and population strategies to curb expenditures; leaves open whether management reduces costs in Japan.
Concerns have increasingly been raised about the medical economic burden in Japan, of which approximately 20% is attributable to cardiovascular disease, including coronary heart disease and stroke. Because the management of risk factors is essential for the prevention of cardiovascular disease, it is important to understand the relationship between cardiovascular risk factors and medical expenditure in the Japanese population. However, only a few Japanese epidemiological studies analysing data on health checkups and medical insurance have provided evidence on this topic. Patients with cardiovascular risk factors, including obesity, hypertension, and diabetes, may incur medical expenditures through treatment of the risk factors themselves and through procedures for associated diseases that usually require hospitalization and sometimes result in death. Untreated risk factors may cause medical expenditure surges, mainly due to long-term hospitalization, more often than risk factors preventively treated by medication. On an individual patient level, medical expenditures increase with the number of concomitant cardiovascular risk factors. For single risk factors, personal medical expenditure may increase with the severity of that factor. However, on a population level, the medical economic burden attributable to cardiovascular risk factors results largely from a single, particularly prevalent risk factor, especially from mildly-to-moderately abnormal levels of the factor. Therefore, cardiovascular risk factors require management on the basis of both a cost-effective strategy of treating high-risk patients and a population strategy for reducing both the ill health and medical economic burdens that result from cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Koshi Nakamura (2014) conducted a review in Cardiovascular risk factors. Cardiovascular risk factors vs. Absence of risk factors was evaluated on Medical expenditure. Cardiovascular risk factors significantly increase individual medical expenditures, while the population-level economic burden is largely driven by prevalent, mildly-to-moderately abnormal risk factor levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: